Pasar al contenido principal

GLICOPEPTIDOS Y GLICOPROTEINAS CON APLICACIONES EN LA TERAPIA Y DIAGNOSTICO DEL CANCER

PID2021-127622OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE LA RIOJA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes

  • Corzana, Francisco
  • Asín, Alicia
  • Eguskiza, Ander
  • De Tomi, Elisa
  • Martín-Carnicero, Alfonso
  • Martínez-Moral, María P.
  • Mangini, Vincenzo
  • Papi, Francesco
  • Bretón, Carmen
  • Oroz, Paula
  • Lagartera, Laura
  • Jiménez-Moreno, Ester
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Nativi, Cristina
  • Asensio, Juan Luis
  • Hurtado-Guerrero, Ramón
  • Peregrina, Jesús M.
  • Malerba, Giovanni
  • Martínez, Alfredo
  • Fiammengo, Roberto
Pancreatic cancer is one of the deadliest cancers worldwide, mainly due to late diagnosis. Therefore, there is an urgent need for novel diagnostic approaches to identify the disease as early as possible. We have developed a diagnostic assay for pancreatic cancer based on the detection of naturally occurring tumor associated autoantibodies against Mucin-1 (MUC1) using engineered glycopeptides on nanoparticle probes. We used a structure-guided approach to develop unnatural glycopeptides as model antigens for tumor-associated MUC1. We designed a collection of 13 glycopeptides to bind either SM3 or 5E5, two monoclonal antibodies with distinct epitopes known to recognize tumor associated MUC1. Glycopeptide binding to SM3 or 5E5 was confirmed by surface plasmon resonance and rationalized by molecular dynamics simulations. These model antigens were conjugated to gold nanoparticles and used in a dot-blot assay to detect autoantibodies in serum samples from pancreatic cancer patients and healthy volunteers. Nanoparticle probes with glycopeptides displaying the SM3 epitope did not have diagnostic potential. Instead, nanoparticle probes displaying glycopeptides with high affinity for 5E5 could discriminate between cancer patients and healthy controls. Remarkably, the best-discriminating probes show significantly better true and false positive rates than the current clinical biomarkers CA19-9 and carcinoembryonic antigen (CEA)., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No956544. We thank Dr. Sara Gasperini of the General Pathology Section, Department of Medicine, University of Verona, for providing access and assistance with the LI–COR Odyssey Infrared Imaging System. We thank Prof.Henrik Clausen from Copenhagen Center for Glycomics atUniversity of Copenhagen for his insightful comments. F.C.thanks the Mizutani Foundation for Glycoscience (grant220115) and AECC (INNOVA 2023 project). A.A. and C.B.thank the Asociación Española Contra el Cáncer (AECC),sección La Rioja, for their doctoral fellow ships. We thank the ALBA (Barcelona, Spain) synchrotron beamline XA-LOC. We thank ARAID, the Agencia Estatal de Investiga-ción (AEI, BFU201675633-P, PID2019-105451GB-I00, and PID2022-136362NB-I00 to R.H.-G., PID2022-136735OB-I00to A.M., PID2021-127030OA-I00 to E.J.-M, PID2022-141085NB-100 to J.L.A, and PID2021-127622OB-I00 andPDC2022-133725-C21 to F.C. and J.H.B.), Universidad de La Rioja (REGI22/47 and REGI22/16), Gobierno de Aragón (E34_R17 and LMP58_18 to R.H.-G.) with FEDER(2014–2020) funds for “Building Europe from Aragón” forfinancial support, and the COST Action CA18103 INNO-GLY: Innovation with Glycans new frontiers from synthesis to new biological targets. CN thanks Fondazione AIRC,project IG25762. Open Access publishing facilitated byUniversità degli Studi di Verona, as part of the Wiley -CRUI-CARE agreement., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Rational design of dual-domain binding inhibitors for N-acetylgalactosamine transferase 2 with improved selectivity over the T1 and T3 isoforms

  • Compañón, Ismael
  • Ballard, Collin J.
  • Lira-Navarrete, Erandi
  • Santos, Tanausú
  • Monaco, Serena
  • Muñoz-García, Juan C.
  • Delso, J. Ignacio
  • Angulo, Jesús
  • Gerken, Thomas A.
  • Schjoldager, Katrine T.
  • Clausen, Henrik
  • Tejero, Tomás
  • Merino, Pedro
  • Corzana, Francisco
  • Hurtado-Guerrero, Ramón
  • Ghirardello, Mattia
The GalNAc-transferase (GalNAc-T) family, consisting of 20 isoenzymes, regulates the O-glycosylation process of mucin glycopeptides by transferring GalNAc units to serine/threonine residues. Dysregulation of specific GalNAc-Ts is associated with various diseases, making these enzymes attractive targets for drug development. The development of inhibitors is key to understanding the implications of GalNAc-Ts in human diseases. However, developing selective inhibitors for individual GalNAc-Ts represents a major challenge due to shared structural similarities among the isoenzymes and some degree of redundancy among the natural substrates. Herein, we report the development of a GalNAc-T2 inhibitor with higher potency compared to those of the T1 and T3 isoforms. The most promising candidate features bivalent GalNAc and thiophene moieties on a peptide chain, enabling binding to both the lectin and catalytic domains of the enzyme. The binding mode was confirmed by competitive saturation transfer difference NMR experiments and validated through molecular dynamics simulations. The inhibitor demonstrated an IC50 of 21.4 μM for GalNAc-T2, with 8- and 32-fold higher selectivity over the T3 and T1 isoforms, respectively, representing a significant step forward in the synthesis of specific GalNAc-T inhibitors tailored to the unique structural features of the targeted isoform., We thank the Agencia Estatal de Investigación (AEI, PID2021-127622OB-I00 and PDC2022-133725-C21 to F.C., PID2022-136362NB-I00 to R.H.-G., PID2022137973NB-I00 to P.M.), Universidad de La Rioja (REGI22/16 Project), and Gobierno de Aragón (E34_R17 and LMP58_18) with FEDER (2014–2020) funds for ‘Building Europe from Aragón’ for financial support (to R.H.-G.). The support of the National Institutes of Health grant R01-GM113535 (to T.A.G.) is also acknowledged. M.G. and I.D. acknowledge the Marie Skłodowska-Curie fellowship program (grant agreement nos. 101034288 (M.G.) and 890779 (I.D.)) for financial support. J.A. and S.M. acknowledge support of BBSRC, grant BB/P010660/1. J.A. and J.C.M.-G. also acknowledge funding from the grant AEI/10.13039/501100011033/PID2022-142879NB-I00, cofunded by the European Regional Development Fund (ERDF), “A way of making Europe”, and T.S. thanks MICIU/AEI /10.13039/501100011033 and the European Union NextGenerationEU/PRTR for his Juan de la Cierva contract, JDC2022-048607-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring photoredox catalytic reactions as an entry to glycosyl-α-amino acids

  • Bretón, Carmen
  • Oroz, Paula
  • Torres, Miguel
  • Zurbano, María M.
  • García-Orduña, Pilar
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Corzana, Francisco
  • Peregrina, Jesús M.
The synthesis of glycosyl-α-amino acids presents a significant challenge due to the need for precise glycosidic linkages connecting carbohydrate moieties to amino acids while maintaining stereo- and regiochemical fidelity. Classical methods relying on ionic intermediates (2e–) often involve intricate synthetic procedures, particularly when dealing with 2-N-acetamido-2-deoxyglycosides linked to α-amino acids—a crucial class of glycoconjugates that play important biological roles. Considering the growing prominence of photocatalysis, this study explores various photoredox catalytic approaches to achieving glycosylation reactions. Our focus lies on the notoriously difficult case of 2-N-acetamido-2-deoxyglycosyl-α-amino acids, which could be obtained efficiently by two methodologies that involved, on the one hand, photoredox Giese reactions using a chiral dehydroalanine (Dha) as an electron density-deficient alkene in these radical 1,4-additions and, on the other hand, photoredox glycosylations using selenoglycosides as glycosyl donors and hydroxyl groups of protected amino acids as acceptors., We thank the Agencia Estatal de Investigación of Spain (AEI; PID2021-127622OB-I00 and PDC2022-133725-C21 projects), the Asociación Española Contra el Cáncer (AECC, INNOVA project 2023), Universidad de La Rioja (REGI22/47 and REGI22/16 projects), and the EU (Marie-Sklodowska Curie ITN, DIRNANO, grant agreement No. 956544). C.B. and M.T. thank (AECC La Rioja) for predoctoral fellowships., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stepwise Hydration Reveals Conformational Switching in Chiral Prolinol

  • Loru, Donatella
  • Alonso, Elena R
  • Insausti, Aran
  • Pérez, Cristóbal
  • Evangelisti, Luca
  • Asensio, Juan Luis
  • Corzana, Francisco
  • Pate, Brooks H
  • Cocinero, Emilio J.
  • Sanz, M Eugenia
Understanding the interactions of chiral molecules with water is crucial, given the central role that water plays in chemical and biological processes. We report the investigation of the amino alcohol prolinol, a widely used chiral catalyst and auxiliary in asymmetric synthesis, and its interactions with one to three water molecules by applying broadband rotational spectroscopy. Bare prolinol adopts two low-energy conformations stabilized by an intramolecular O-H···N hydrogen bond. Upon complexation with a single water molecule, four prolinol-H2O isomers are identified, showing addition and insertion structures, where the original prolinol conformations are conserved. Notably, complexation with two and three water molecules induces prolinol to adopt its highest energy conformations, which lie more than 9.5 kJ mol-1 above the global minimum and feature an intramolecular N-H···O hydrogen bond. In prolinol-(H2O)2,3, water acts as a conformational switch for prolinol, binding to both the amino and hydroxyl groups. Combined NMR studies and molecular dynamics simulations reveal that, in bulk water, prolinol exists as a highly flexible conformational ensemble, with no evidence of a stable intramolecular hydrogen bond, and mainly samples the same conformational space as that displayed in prolinol-(H2O)2,3. Our results illustrate how stepwise hydration proceeds and reveal the profound changes that water can induce in flexible chiral molecules. These findings provide a solid foundation for future experiments and modeling of solvation-induced processes., D.L. and M.E.S. acknowledge funding from UE FP7 (grant PCIG12-GA-2012-334525), King’s College London, and EPSRC (EP/X039420/1). E.J.C. acknowledges financial support from the Spanish Ministry of Science and Innovation (MCIN/AEI, Project PID2023-147698NB-I00) and the Basque Government (Project IT1491-22). L.E. thanks the CINECA award under the ISCRA initiative, for the availability of high-performance computing resources and support, and the project PRIN2022, MUR code 2022WKTH9ECUP J53D23008810006. C.P. acknowledges the ERC for the CoG HydroChiral Grant Agreement 101124939. J.L. and F.C. thank the Agencia Estatal de Investigacioń (AEI, PID2022- 141085NB-I00, PID2021-127622OB-I00 and PID2024- 161682OB-I00)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Molecular recognition of GalNAc in mucin-type o-glycosylation

  • Sanz-Martinez, I.
  • Pereira, S.
  • Merino, P.
  • Corzana, F.
  • Hurtado-Guerrero, R.
N-Acetylgalactosamine (GalNAc)-type O-glycosylation is an essential posttranslational modification (PTM) that plays fundamental roles in biology. Malfunction of this PTM is exemplified by the presence of truncated O-glycans in cancer. For instance, the glycoprotein MUC1 is overexpressed in many tumor tissues and tends to carry simple oligosaccharides that allow for the presentation of different tumor-associated antigens, such as the Tn or sTn antigens (GalNAc-α-1-O-Thr/Ser and Neu5Acα2-6GalNAcα1-O-Ser/Thr, respectively). In other cases, such as tumoral calcinosis associated with O-glycosylation of the fibroblast growth factor 23, O-glycans are absent or less abundant. Significant progress has been made in determining the three-dimensional structures of biomolecules that recognize GalNAc, such as antibodies, lectins, mucinases, GalNAc-transferases, and other glycosyltransferases. Analysis of the complexes between these entities and GalNAc-containing glycopeptides, in most cases derived from crystallographic or NMR analysis, provides an understanding of the key structural elements that control molecular recognition of these glycopeptides. Here, we describe and compare the binding sites of these proteins in detail, focusing on how the GalNAc moieties interact selectively with them. We also summarize the differences and similarities in GalNAc recognition. In general, the recognition of GalNAc-containing glycopeptides is determined by hydrogen bonds between hydroxyl groups and the N-acetyl group of GalNAc with proteins, as well as CH-π contacts in which the hydrophobic α-face of the sugar and the methyl group of NHAc can be involved. The latter interaction usually provides the basis for selectivity. It is worth noting that binding of these glycopeptides depends primarily on recognition of the sugar moiety, with some exceptions such as a few anti-MUC1 antibodies that primarily recognize the peptide backbone and use the sugar to facilitate shape complementarity or to establish a limited number of interactions with the protein. Focusing specifically on the GalNAc moiety, we can observe that there is some degeneracy of interactions within the same protein families, likely due to substrate flexibility. However, when all studied proteins are considered together, despite the commonalities within each protein family, no pattern can be discerned between the different families, apart from the presence of common residues such as Tyr, His, or Asp, which are responsible for hydrogen bonds. The lack of a pattern can be anticipated, given the diverse functions of mucinases, glycosyltransferases, antibodies, and lectins. Finally, it is important to point out that the conformational differences observed in solution in glycopeptides bearing GalNAc-α-1-O-Ser or GalNAc-α-1-O-Thr also can be found in the bound state. This unique characteristic is exploited, for instance, by the enzyme C1GalT1 to broadly glycosylate both acceptor substrates. The findings summarized in this review may contribute to the rational structure-guided development of therapeutic vaccines, novel diagnostic tools for early cancer detection, and new cancer treatments for cancer with tailored anti-Tn or anti-STn antibodies or new drugs to inhibit GalNAc-T isoenzymes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase

  • Piniello, Beatriz
  • Macías-León, Javier
  • Miyazaki, Shun
  • García-García, Ana
  • Compañón, Ismael
  • Ghirardello, Mattia
  • Taleb, Víctor
  • Veloz, Billy
  • Corzana, Francisco
  • Miyagawa, Atsushi
  • Rovira, Carme
  • Hurtado-Guerrero, Ramon
Soluble HMW1C-like N-glycosyltransferases (NGTs) catalyze the glycosylation of Asn residues in proteins, a process fundamental for bacterial autoaggregation, adhesion and pathogenicity. However, our understanding of their molecular mechanisms is hindered by the lack of structures of enzymatic complexes. Here, we report structures of binary and ternary NGT complexes of Aggregatibacter aphrophilus NGT (AaNGT), revealing an essential dyad of basic/acidic residues located in the N-terminal all α-domain (AAD) that intimately recognizes the Thr residue within the conserved motif Asn0-X+1-Ser/Thr+2. Poor substrates and inhibitors such as UDP-galactose and UDP-glucose mimetics adopt non-productive conformations, decreasing or impeding catalysis. QM/MM simulations rationalize these results, showing that AaNGT follows a SN2 reaction mechanism in which the acceptor asparagine uses its imidic form for catalysis and the UDP-glucose phosphate group acts as a general base. These findings provide key insights into the mechanism of NGTs and will facilitate the design of structure-based inhibitors to treat diseases caused by non-typeable H. influenzae or other Gram-negative bacteria.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Detection of tumor-associated autoantibodies in the sera of pancreatic cancer patients using engineered muc1 glycopeptide nanoparticle probes

  • Corzana, Francisco
  • Asín, Alicia
  • Eguskiza, Ander
  • De Tomi, Elisa
  • Martín-Carnicero, Alfonso
  • Martínez-Moral, María P.
  • Mangini, Vincenzo
  • Papi, Francesco
  • Bretón, Carmen
  • Oroz, Paula
  • Lagartera, Laura
  • Jiménez-Moreno, Ester
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Nativi, Cristina
  • Asensio, Juan L.
  • Hurtado-Guerrero, Ramón
  • Peregrina, Jesús M.
  • Malerba, Giovanni
  • Martínez, Alfredo
  • Fiammengo, Roberto
Pancreatic cancer is one of the deadliest cancers worldwide, mainly due to late diagnosis. Therefore, there is an urgent need for novel diagnostic approaches to identify the disease as early as possible. We have developed a diagnostic assay for pancreatic cancer based on the detection of naturally occurring tumor associated autoantibodies against Mucin‐1 (MUC1) using engineered glycopeptides on nanoparticle probes. We used a structure‐guided approach to develop unnatural glycopeptides as model antigens for tumor‐associated MUC1. We designed a collection of 13 glycopeptides to bind either SM3 or 5E5, two monoclonal antibodies with distinct epitopes known to recognize tumor associated MUC1. Glycopeptide binding to SM3 or 5E5 was confirmed by surface plasmon resonance and rationalized by molecular dynamics simulations. These model antigens were conjugated to gold nanoparticles and used in a dot‐blot assay to detect autoantibodies in serum samples from pancreatic cancer patients and healthy volunteers. Nanoparticle probes with glycopeptides displaying the SM3 epitope did not have diagnostic potential. Instead, nanoparticle probes displaying glycopeptides with high affinity for 5E5 could discriminate between cancer patients and healthy controls. Remarkably, the best‐discriminating probes show significantly better true and false positive rates than the current clinical biomarkers CA19‐9 and carcinoembryonic antigen (CEA).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Exploring Photoredox Catalytic Reactions as an Entry to Glycosyl-a-amino Acids

  • Bretón, Carmen
  • Oroz, Paula
  • Torres, Miguel
  • Zurbano, María M.
  • García-Orduña, Pilar
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Corzana, Francisco
  • Peregrina, Jesús M.
The synthesis of glycosyl-α-amino acids presents a significant challenge due to the need for precise glycosidic linkages connecting carbohydrate moieties to amino acids while maintaining stereo- and regiochemical fidelity. Classical methods relying on ionic intermediates (2e–) often involve intricate synthetic procedures, particularly when dealing with 2-N-acetamido-2-deoxyglycosides linked to α-amino acids─a crucial class of glycoconjugates that play important biological roles. Considering the growing prominence of photocatalysis, this study explores various photoredox catalytic approaches to achieving glycosylation reactions. Our focus lies on the notoriously difficult case of 2-N-acetamido-2-deoxyglycosyl-α-amino acids, which could be obtained efficiently by two methodologies that involved, on the one hand, photoredox Giese reactions using a chiral dehydroalanine (Dha) as an electron density-deficient alkene in these radical 1,4-additions and, on the other hand, photoredox glycosylations using selenoglycosides as glycosyl donors and hydroxyl groups of protected amino acids as acceptors.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

An organometallic approach to sub-2 nm thiolate-protected Au nanoclusters with enhanced catalytic and therapeutic properties

  • del-Campo, Irene
  • Sorroche, Alba
  • Allen, Nina
  • Ghirardello, Mattia
  • Corzana, Francisco
  • Galán, M. Carmen
  • Monge, Miguel
  • López-de-Luzuriaga, José M.
Thiolate-protected gold nanoclusters (AuNCs) of sub-2 nm size have been synthesized through a novel bottom-up approach using the organometallic precursor [Au(C6F5)(tht)] (tht = tetrahydrothiophene) in a one-pot reaction under mild conditions. This protocol is simple, rapid (1 h), versatile (applicable to thiolate ligands of varying molecular sizes), and reproducible, yielding AuNCs with low size dispersion. Furthermore, the resulting nanomaterials exhibited remarkable catalytic activity, effectively reducing the pollutant 4-nitrophenol to 4-aminophenol, as well as promising photothermal and photodynamic properties upon exposure to an 808 nm laser, converting light into thermal energy and generating reactive oxygen species (ROS). Additionally, AuNCs stabilized with a nonapeptide demonstrated efficient catalase-like activity, thereby potentially enhancing the efficacy of photodynamic therapy. The cytotoxic effects against cancer (HeLa) and healthy cells (HDF) were also evaluated, showing greater selectivity for HeLa cells, with higher toxicity and increased ROS generation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Structure-guided phage display discovery of antibodies for (S)Tn-glycans in protein context

  • Hurtado-Guerrero, Ramón
  • Spyridon, Gatos
  • Ginés-Alcober, Irene
  • Macías-León, Javier
  • González-Ramírez, Andrés Manuel
  • Kasapoglu, Ilknur
  • Veloz, Billy
  • Compañón, Ismael
  • Ghirardello, Mattia
  • Merino, Pedro
  • Corzana, Francisco
  • Blixt, Ola
Developing high-affinity monoclonal antibodies (mAbs) against tumor-associated carbohydrate antigens such as Tn and STn on carrier proteins remains a major challenge in cancer therapy. These antigens, expressed as glycan–peptide epitopes (combotopes), require precise recognition for high specificity. Through structural studies, we found that VH domains of certain antibodies primarily recognize glycans, whereas VL domains bind peptide sequences. Using these insights, we developed a VH-focused and VL-diverse phage display library to discover mAbs with combotope-binding characteristics. Notably, structural analysis enabled us to convert Tn-specific mAbs into STn-specific mAbs through modification of VH complementarity-determining region 3, demonstrating the versatility of this approach. Our hypothesis was validated with glycoprotein targets MUC1 and CD43, yielding antibodies with high specificity and affinity. Furthermore, internalization studies using the parental antibody scaffold show efficient uptake by tumor cells, supporting its use in antibody–drug conjugates. This platform addresses the challenge of generating glycoform-specific antibodies for cancer therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Microbial binding module employs sophisticated clustered saccharide patches to selectively adhere to mucins

  • Jaroentomeechai, Thapakorn
  • Veloz, Billy
  • Soares, Cátia O.
  • Goerdeler, Felix
  • Grosso, Ana Sofia
  • Büll, Christian
  • Miller, Rebecca L.
  • Furukawa, Sanae
  • Ginés-Alcober, Irene
  • Taleb, Víctor
  • Merino, Pedro
  • Ghirardello, Mattia
  • Compañón, Ismael
  • Coelho, Helena
  • Dias, Jorge S.
  • Vincentelli, Renaud
  • Henrissat, Bernard
  • Joshi, Hiren
  • Clausen, Henrik
  • Corzana, Francisco
  • Marcelo, Filipa
  • Hurtado-Guerrero, Ramon
  • Narimatsu, Yoshiki
The mucus lining wet body surfaces forms the interphase and barrier for the microbiota and resident microbiomes. Large mucin proteins densely decorated with O-glycans make up the mucus lining to entrap, feed and shape the microbiota, and repress biofilm formation and virulence. How mucins exert these effects is poorly understood and critical is how the microbiota recognize, sense, and break down mucins. Here, we provide structural molecular evidence that a small mucin-binding module designated X409 recognizes clustered saccharide patches comprised of rows of inner monosaccharides in adjacent O-glycans. These patches are unique to mucins and binding to these provides an elegant mechanism to retain adherence to mucins despite trimming of O-glycans during microbial scavenging of monosaccharides from mucins. Realization of clustered saccharide patch-binding motifs provides a hitherto overlooked scenario of contextual glycan epitopes and impetus for discovery of new classes of glycan-binding proteins.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Discovery of a secreted Bacteroides fragilis mucinase that cleaves mucins with bis-T O-glycans through a carbohydrate binding module-dependent mechanism

  • Narimatsu, Yoshiki
  • Pleguezuelos-Manzano, Cayetano
  • Hornikx, Daniel
  • Goerdeler, Felix
  • Jaroentomeechai, Thapakorn
  • Flores, Katia
  • Narimatsu, Sanae
  • Boot, Charelle
  • Hansen, Lars
  • Durbesson, Fabien
  • Vincentelli, Renaud
  • Comstock, Laurie
  • Clevers, Hans
  • Taleb, Victor
  • Corzana, Francisco
  • Henrissat, Bernard
  • Clausen, Henrik
  • Hurtado-Guerrero, Ramón
  • Büll, Christian
Degradation of mucins at the host–microbial mucus interphase involves glycosidases that release monosaccharides from O-glycans and mucinases that cleave the mucin protein backbone. Mucinases recognize and cleave peptide bonds at specific sequence motifs with varying O-glycan structures required and/or permissible. Mucinases that digest mucins with intact O-glycans can potentially destroy the protective mucus, while mucinases that only digest mucins with partially degraded O-glycans may serve at a later stage of nutrient sourcing from mucins. Here, we discovered nine CBM-bearing M60-like mucinases across gut commensals and opportunists, including a conserved Bacteroides fragilis mucinase denoted HC11. We also investigated the previously described Bacteroides thetaiotaomicron mucinase BT4244, which together delineates two functional classes with distinct preferences: BT4244 for bis-Tn (GalNAcα1-O-Ser/Thr) and HC11 for bis-T (Galβ1-3GalNAcα1-O-Ser/Thr) O-glycans. Both mucinases harbor carbohydrate-binding modules (CBM32) that bind their cognate O-glycan motifs and are required – together with the catalytic domains – for efficient cleavage of extended mucin domains, which is consistent with cooperative engagement, but are not required for the cleavage of short glycopeptides. We show B. fragilis strains secrete HC11 and degrade mucins only after the removal of sialic acids. Together, these findings expand the mucinase repertoire by nine enzymes spanning commensals and opportunists, demonstrate that CBM32 domains are essential for efficient cleavage of extended mucin substrates likely by promoting multivalent engagement and substrate positioning, and nominateidentify CBM–catalytic cooperation as a mechanism and intervention point for controlling mucus turnover and barrier integrity.